chr10-14936550-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
This summary comes from the ClinGen Evidence Repository: NM_001033855.3(DCLRE1C):c.350C>T is a missense variant predicted to cause substitution of Proline by Leucine at amino acid 117 (p.Pro117Leu). The filtering allele frequency (the upper threshold of the 95% CI of 50/1178836) of the c.350C>T variant in DCLRE1C is 0.00003376 for European (non-Finnish) chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting, and therefore do not meet this criterion.To our knowledge, this variant has not been reported in the literature in individuals affected with SCID/DCLRE1C-related conditions or in functional studies.In summary, this variant meets the criteria to be classified as a Variant of Uncertain Significance for autosomal recessive severe combined immunodeficiency due to DCLRE1C deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP (specification version 1.0): No criteria were applied. LINK:https://erepo.genome.network/evrepo/ui/classification/CA5416895/MONDO:0011225/116
Frequency
Consequence
NM_001033855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCLRE1C | NM_001033855.3 | c.350C>T | p.Pro117Leu | missense_variant | 5/14 | ENST00000378278.7 | NP_001029027.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCLRE1C | ENST00000378278.7 | c.350C>T | p.Pro117Leu | missense_variant | 5/14 | 1 | NM_001033855.3 | ENSP00000367527 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151770Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251150Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135814
GnomAD4 exome AF: 0.0000370 AC: 54AN: 1460542Hom.: 0 Cov.: 29 AF XY: 0.0000385 AC XY: 28AN XY: 726656
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151770Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74094
ClinVar
Submissions by phenotype
Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 26, 2021 | This sequence change replaces proline with leucine at codon 117 of the DCLRE1C protein (p.Pro117Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs757316102, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with DCLRE1C-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, reviewed by expert panel | curation | ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen | Feb 15, 2024 | NM_001033855.3(DCLRE1C):c.350C>T is a missense variant predicted to cause substitution of Proline by Leucine at amino acid 117 (p.Pro117Leu). The filtering allele frequency (the upper threshold of the 95% CI of 50/1178836) of the c.350C>T variant in DCLRE1C is 0.00003376 for European (non-Finnish) chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting, and therefore do not meet this criterion. To our knowledge, this variant has not been reported in the literature in individuals affected with SCID/DCLRE1C-related conditions or in functional studies. In summary, this variant meets the criteria to be classified as a Variant of Uncertain Significance for autosomal recessive severe combined immunodeficiency due to DCLRE1C deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP (specification version 1.0): No criteria were applied. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 19, 2023 | Variant summary: DCLRE1C c.350C>T (p.Pro117Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 251150 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.350C>T in individuals affected with Severe Combined Immunodeficiency and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance and one ClinVar submitter (evaluation after 2014) cites it as likely pathogenic. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Athabaskan severe combined immunodeficiency Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 15, 2021 | - - |
Histiocytic medullary reticulosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 11, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 02, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at